BOT 5.97% 35.5¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-67

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,685 Posts.
    lightbulb Created with Sketch. 108
    Great post as always mate..

    Argo did their job, they also made plenty. There were 10 bags in it for Argo and many of their clients from 2 cents to 20. In hindsight they looked after their client base. Phase 2 is a whole different kettle of fish though mate and being fully funded and running phase 2 trials concurrently is genuis.

    We are now playing with the big boys. Big pharma are no doubt watching every move.


    I got some interesting mail recently about who has been buying from September to last Friday the 21st:


    Brokers buying, retail selling.

    Smart money in, dumb money out.

    This stock will be absolutely life changing.

    Cheers.
    Last edited by bernsta: 29/12/18
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.020(5.97%)
Mkt cap ! $707.4M
Open High Low Value Volume
33.5¢ 36.0¢ 33.3¢ $2.622M 7.530M

Buyers (Bids)

No. Vol. Price($)
5 106888 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 462320 5
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.